“…In contrast, triple-negative breast cancer is frequently treated with chemotherapeutic agents like Doxorubicin, Cyclophosphamide, and Vinorelbine Tartrate. However, these widely used chemotherapy drugs in clinical settings are often associated with a range of side effects, including gastrointestinal disturbances ( Zhou et al, 2013 ; Sartaj et al, 2021a ; Farghadani and Naidu, 2022 ), osteoporosis ( Essex et al, 2019 ; Shapiro, 2021 ; Meyer et al, 2024 ), bone marrow suppression ( Zhou et al, 2013 ; Koliou et al, 2018 ; Han et al, 2021 ), dyslipidemia ( Duman et al, 2012 ), and drug resistance ( Sartaj et al, 2021b ; Yu S. W. et al, 2023 ). On the other hand, TCM has demonstrated broad applicability in various types and clinical stages of breast cancer.…”